Skip to main content

Table 5 The expression of vimentin protein in different components of PESC

From: The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma

 

Number

Expression rate of vimentin protein (%)

Positive in epithelial component (%)

Positive in spindle component (%)

Positive in both of epithelial and spindle components (%)

χ 2

P

Age

  < 60 years

26

26 (100.0)

2 (7.7)

26 (100.0)

2 (7.7)

0.15

1.000

  ≥ 60 years

56

56 (100.0)

5 (8.9)

56 (100.0)

5 (8.9)

Gender

 Male

57

57 (100.0)

5 (8.8)

57 (100.0)

5 (8.8)

0.15

1.000

 Female

25

25 (100.0)

2 (8.0)

25 (100.0)

2 (8.0)

Family history

 Positive

18

18 (100.0)

3 (16.7)

18 (100.0)

3 (16.7)

3.347

0.309

 Negative

64

64 (100.0)

4 (6.3)

64 (100.0)

4 (6.3)

Smoking

 Yes

41

41 (100.0)

4 (9.8)

41 (100.0)

4 (9.8)

0.379

1.000

 No

41

41 (100.0)

3 (7.3)

41 (100.0)

3 (7.3)

Alcohol

 Yes

36

36 (100.0)

5 (13.9)

36 (100.0)

5 (13.9)

3.782

0.282

 No

46

46 (100.0)

2 (4.3)

46 (100.0)

2 (4.3)

Tumor location

 Upper

3

3 (100.0)

0 (0.0)

3 (100.0)

0 (0.0)

1.57

0.832

 Middle

54

54 (100.0)

4 (7.4)

54 (100.0)

4 (7.4)

 Lower

25

25 (100.0)

3 (12.0)

25 (100.0)

3 (12.0)

Gross appearance

 Polypoid

69

69 (100.0)

5 (7.2)

69 (100.0)

5 (7.2)

7.59

0.188

 Ulcerative

8

8 (100.0)

0 (0.0)

8 (100.0)

0 (0.0)

 Infiltrating

5

5 (100.0)

2 (40.0)

5 (100.0)

2 (40.0)

Lymph node metastasis

 Yes

23

23 (100.0)

2 (8.7)

23 (100.0)

2 (8.7)

0.21

1.000

 No

59

59 (100.0)

5 (8.5)

59 (100.0)

5 (8.5)

TNM stage

 I

29

29 (100.0)

0 (0.0)

29 (100.0)

0 (0.0)

7.50

0.067

 II

37

37 (100.0)

5 (13.5)

37 (100.0)

5 (13.5)

 III

16

16 (100.0)

2 (12.5)

16 (100.0)

2 (12.5)

 IV

0

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)